Page results
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Fiona Farrell works at the Sir William Gowers Unit, a specialist treatment centre for epilepsy and related disorders.
-
Information about our UCLH Charity, charity funds and associated charities.
File results
-
FOI/2024/0506 - Permanent/ fixed-term/ international recruitment
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy